1. Rapid-CNS2: rapid comprehensive adaptive nanopore-sequencing of CNS tumors, a proof-of-concept study.
- Author
-
Patel, Areeba, Dogan, Helin, Payne, Alexander, Krause, Elena, Sievers, Philipp, Schoebe, Natalie, Schrimpf, Daniel, Blume, Christina, Stichel, Damian, Holmes, Nadine, Euskirchen, Philipp, Hench, Jürgen, Frank, Stephan, Rosenstiel-Goidts, Violaine, Ratliff, Miriam, Etminan, Nima, Unterberg, Andreas, Dieterich, Christoph, Herold-Mende, Christel, and Pfister, Stefan M.
- Subjects
- *
NERVOUS system tumors - Abstract
The glioma samples run with the Rapid CNS A panel as target region were each loaded onto FLO-MIN106 R9.4.1 flow cells and sequencing was controlled in real-time by ReadFish (using a GPU powered consumer notebook). "PANEL A" indicates samples sequenced using Rapid CNS A, and "PANEL B" indicates samples sequenced using Rapid CNS B (sample by Rapid-CNS2 and 850 k identified as AT/RT excluded, depicted in Supplementary Fig. One sample identified as a glioma by histology was correctly classified as an atypical teratoid/rhabdoid tumor by Rapid-CNS SP 2 sp (confirmed by EPIC array analysis, Supplementary Fig. [Extracted from the article]
- Published
- 2022
- Full Text
- View/download PDF